Financial statements Apteka Gemini
Cash inflows of APTEKA GEMINI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|---|---|---|
| Net cash from operating expenses | -6 681 103,65 | 7 319 427,79 | 7 363 245,68 | 6 347 277,84 | 11 301 278,70 | 17 941 877,96 | 8 242 525,25 | 2 598 074,44 |
| Net cash flow from investing activities | -251 746,63 | -321 951,76 | -1 173 837,14 | -221 368,85 | -323 929,06 | -10 017 865,15 | -8 878 032,80 | 7 158 172,39 |
| Net cash flow from financial activities | 7 081 434,10 | -5 941 684,38 | -7 256 932,86 | -929 173,33 | -8 103 295,36 | -1 481 672,19 | -1 608 326,45 | -1 088 843,74 |
| Total net cash flow | 148 583,82 | 1 055 791,65 | -1 067 524,32 | 5 196 735,66 | 2 874 054,28 | 6 442 340,62 | -2 243 834,00 | 8 667 403,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
AD
AD